|
Kazhdan, I; Long, L; Montellano, R et al. (2006) Targeted gene therapy for breast cancer with truncated Bid. Cancer Gene Ther 13:141-9
|
|
Kazhdan, Irene; Marciniak, Robert A (2004) Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Cancer Gene Ther 11:691-8
|
|
Wang, W; Waters, S J; MacDonald, J R et al. (2001) Irofulven (6-hydroxymethylacylfulvene, MGI 114) induces caspase 8 and 9-mediated apoptosis in human pancreatic adenocarcinoma cells. Anticancer Res 21:1789-94
|
|
Raymond, E; Sun, D; Izbicka, E et al. (1999) A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. Br J Cancer 80:1332-41
|
|
Yang, L M; Tin-U, C; Wu, K et al. (1999) Role of retinoid receptors in the prevention and treatment of breast cancer. J Mammary Gland Biol Neoplasia 4:377-88
|
|
Sharma, S; Raymond, E; Soda, H et al. (1998) Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. Leuk Res 22:663-70
|
|
Sharma, J J; Razvillas, B; Stephens, C D et al. (1997) Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer. Invest New Drugs 15:361-4
|
|
Sharma, S; Raymond, E; Soda, H et al. (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann Oncol 8:1063-74
|
|
Alsina, M; Boyce, B; Devlin, R D et al. (1996) Development of an in vivo model of human multiple myeloma bone disease. Blood 87:1495-501
|
|
Alsina, M; Boyce, B F; Mundy, G R et al. (1995) An in vivo model of human multiple myeloma bone disease. Stem Cells 13 Suppl 2:48-50
|
Showing the most recent 10 out of 11 publications
